Beijing Konruns Pharmaceutical Co Ltd

SSE:603590

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Beijing Konruns Pharmaceutical Co Ltd's stock price target?

Price Target

44.55 CNY

According to Wall Street analysts, the average 1-year price target for Beijing Konruns Pharmaceutical Co Ltd is 44.55 CNY .

What is Beijing Konruns Pharmaceutical Co Ltd's Revenue forecast?

Projected CAGR

22%

For the last 6 years the compound annual growth rate for Beijing Konruns Pharmaceutical Co Ltd's revenue is 17%. The projected CAGR for the next 3 years is 22%.

What is Beijing Konruns Pharmaceutical Co Ltd's Operating Income forecast?

Projected CAGR

33%

For the last 6 years the compound annual growth rate for Beijing Konruns Pharmaceutical Co Ltd's operating income is -3%. The projected CAGR for the next 2 years is 33%.

What is Beijing Konruns Pharmaceutical Co Ltd's Net Income forecast?

Projected CAGR

31%

For the last 6 years the compound annual growth rate for Beijing Konruns Pharmaceutical Co Ltd's net income is -10%. The projected CAGR for the next 3 years is 31%.